Novartis, Pfizer join forces on potentially lucrative fatty liver disease

Novartis AG and Pfizer Inc are teaming up to develop treatments for a liver disease many drug companies believe will become a hugely lucrative market, as it is tied to the obesity and diabetes epidemics.

from Reuters: Health News https://ift.tt/2yGdGIK
via IFTTT